Q-omics provides the consensus-scored MTND2P22 profile across patient tissues and cancer cell-line models. MTND2P22 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in MESO. Additionally, MTND2P22 RNA expression shows 1,993 significant gene co-expression associations, with the highest sampling consensus in THCA. Together, these results highlight MESO, and THCA as cancer lineages where MTND2P22 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MTND2P22 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MTND2P22 survival associations across molecular data types. MTND2P22 RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MTND2P22 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	8	MESO (81)	view →

This table ranks reproducible MTND2P22 RNA expression–survival associations across cancer types. High MTND2P22 expression shows unfavorable associations in MESO, SKCM, LUSC and SARC, but favorable associations in HNSC and LUAD. The MESO Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .004). Together, the overview and detailed table identify MESO as the clearest survival context for MTND2P22 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.186	0.572	.004	81	view →
HNSC	DFS	Tertile	II,III,IV	0.912	0.310	.011	54	view →
SKCM	DFS	Tertile	II,III,IV	0.310	0.717	<.001	21	view →
LUSC	OS	Tertile	All	0.287	0.733	.001	18	view →
SARC	OS	Tertile	All	0.022	0.861	<.001	18	view →
LUAD	DFS	Tertile	All	1.000	0.334	.018	15	view →

Pink = unfavorable, green = favorable. all 8 lineages →

MTND2P22-MESO (OS)

Kaplan–Meier survival curve for MTND2P22 RNA expression in MESO: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MTND2P22 in patient tissues and cancer cell lines. In patient samples, MTND2P22 shows the broadest associations at the RNA and protein expression levels, with THCA recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	1,993	THCA (412)	view →
Function (RNA)	1,891	STAD (1113)	view →